Literature DB >> 19056342

Loss of Purkinje cells in the PKCgamma H101Y transgenic mouse.

Yunong Zhang1, Adam Snider, Lloyd Willard, Dolores J Takemoto, Dingbo Lin.   

Abstract

Spinocerebellar ataxia type 14 (SCA14) is an autosomal, dominant neurodegenerative disorder caused by mutations in PKCgamma. The objective of this study was to determine effects of PKCgamma H101Y SCA14 mutation on Purkinje cells in the transgenic mouse. Results demonstrated that wild type PKCgamma-like Purkinje cell localization of HA-tagged PKCgamma H101Y mutant proteins, altered morphology and loss of Purkinje cells were observed in the PKCgamma H101Y SCA14 transgenic mouse at four weeks of age. Failure of stereotypical clasping responses in the hind limbs of transgenic mice was also observed. Further, PKCgamma H101Y SCA14 mutation caused lack of total cellular PKCgamma enzyme activity, loss of connexin 57 phosphorylation on serines, and activation of caspase-12 in the PKCgamma H101Y SCA14 transgenic mouse. Results clearly demonstrate a need for PKCgamma control of gap junctions for maintenance of Purkinje cells. This is the first transgenic mouse to our knowledge which models a human SCA14 mutation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19056342      PMCID: PMC4079109          DOI: 10.1016/j.bbrc.2008.11.082

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  30 in total

1.  Protein kinase C gamma mutations in spinocerebellar ataxia 14 increase kinase activity and alter membrane targeting.

Authors:  D S Verbeek; M A Knight; G G Harmison; K H Fischbeck; B W Howell
Journal:  Brain       Date:  2004-12-23       Impact factor: 13.501

2.  Mutant protein kinase Cgamma found in spinocerebellar ataxia type 14 is susceptible to aggregation and causes cell death.

Authors:  Takahiro Seki; Naoko Adachi; Yoshitaka Ono; Hideki Mochizuki; Keiko Hiramoto; Taku Amano; Hiroaki Matsubayashi; Masayasu Matsumoto; Hideshi Kawakami; Naoaki Saito; Norio Sakai
Journal:  J Biol Chem       Date:  2005-06-17       Impact factor: 5.157

3.  The clinical and genetic spectrum of spinocerebellar ataxia 14.

Authors:  D-H Chen; P J Cimino; L P W Ranum; H Y Zoghbi; I Yabe; L Schut; R L Margolis; H P Lipe; A Feleke; M Matsushita; J Wolff; C Morgan; D Lau; M Fernandez; H Sasaki; W H Raskind; T D Bird
Journal:  Neurology       Date:  2005-04-12       Impact factor: 9.910

4.  Long-term maintenance of mature hippocampal slices in vitro.

Authors:  Z Xiang; S Hrabetova; S I Moskowitz; P Casaccia-Bonnefil; S R Young; V C Nimmrich; H Tiedge; S Einheber; S Karnup; R Bianchi; P J Bergold
Journal:  J Neurosci Methods       Date:  2000-06-01       Impact factor: 2.390

5.  Oxidative activation of protein kinase Cgamma through the C1 domain. Effects on gap junctions.

Authors:  Dingbo Lin; Dolores J Takemoto
Journal:  J Biol Chem       Date:  2005-01-10       Impact factor: 5.157

6.  Expansion of the phenotypic spectrum of SCA14 caused by the Gly128Asp mutation in PRKCG.

Authors:  Shiroh Miura; Hiroko Nakagawara; Hayato Kaida; Minoru Sugita; Kazuhito Noda; Kyoko Motomura; Yasumasa Ohyagi; Mitsuyoshi Ayabe; Hisamichi Aizawa; Masatoshi Ishibashi; Takayuki Taniwaki
Journal:  Clin Neurol Neurosurg       Date:  2008-11-04       Impact factor: 1.876

7.  Mutation in the catalytic domain of protein kinase C gamma and extension of the phenotype associated with spinocerebellar ataxia type 14.

Authors:  Giovanni Stevanin; Valérie Hahn; Ebba Lohmann; Naima Bouslam; Michel Gouttard; Caroline Soumphonphakdy; Marie-Laure Welter; Elisabeth Ollagnon-Roman; Arnaud Lemainque; Merle Ruberg; Alexis Brice; Alexandra Durr
Journal:  Arch Neurol       Date:  2004-08

8.  Spinocerebellar ataxia type 14 caused by a mutation in protein kinase C gamma.

Authors:  Ichiro Yabe; Hidenao Sasaki; Dong-Hui Chen; Wendy H Raskind; Thomas D Bird; Isao Yamashita; Shoji Tsuji; Seiji Kikuchi; Kunio Tashiro
Journal:  Arch Neurol       Date:  2003-12

9.  Identification of a novel SCA14 mutation in a Dutch autosomal dominant cerebellar ataxia family.

Authors:  B P C van de Warrenburg; D S Verbeek; S J Piersma; F A M Hennekam; P L Pearson; N V A M Knoers; H P H Kremer; R J Sinke
Journal:  Neurology       Date:  2003-12-23       Impact factor: 9.910

10.  Protein disulfide bond formation in the cytoplasm during oxidative stress.

Authors:  Robert C Cumming; Nancy L Andon; Paul A Haynes; Minkyu Park; Wolfgang H Fischer; David Schubert
Journal:  J Biol Chem       Date:  2004-03-18       Impact factor: 5.157

View more
  7 in total

Review 1.  Genetically engineered mouse models of the trinucleotide-repeat spinocerebellar ataxias.

Authors:  Melissa A C Ingram; Harry T Orr; H Brent Clark
Journal:  Brain Res Bull       Date:  2011-07-23       Impact factor: 4.077

2.  Consensus Paper: Strengths and Weaknesses of Animal Models of Spinocerebellar Ataxias and Their Clinical Implications.

Authors:  Jan Cendelin; Marija Cvetanovic; Mandi Gandelman; Hirokazu Hirai; Harry T Orr; Stefan M Pulst; Michael Strupp; Filip Tichanek; Jan Tuma; Mario Manto
Journal:  Cerebellum       Date:  2021-08-10       Impact factor: 3.648

Review 3.  Emerging pathogenic pathways in the spinocerebellar ataxias.

Authors:  Kerri M Carlson; J Michael Andresen; Harry T Orr
Journal:  Curr Opin Genet Dev       Date:  2009-04-01       Impact factor: 5.578

4.  ERK/p90(RSK)/14-3-3 signalling has an impact on expression of PEA3 Ets transcription factors via the transcriptional repressor capicúa.

Authors:  Kumara Dissanayake; Rachel Toth; Jamie Blakey; Olof Olsson; David G Campbell; Alan R Prescott; Carol MacKintosh
Journal:  Biochem J       Date:  2011-02-01       Impact factor: 3.857

Review 5.  Calcium Signaling, PKC Gamma, IP3R1 and CAR8 Link Spinocerebellar Ataxias and Purkinje Cell Dendritic Development.

Authors:  Etsuko Shimobayashi; Josef P Kapfhammer
Journal:  Curr Neuropharmacol       Date:  2018-01-30       Impact factor: 7.363

Review 6.  The Emerging Key Role of the mGluR1-PKCγ Signaling Pathway in the Pathogenesis of Spinocerebellar Ataxias: A Neurodevelopmental Viewpoint.

Authors:  Qin-Wei Wu; Josef P Kapfhammer
Journal:  Int J Mol Sci       Date:  2022-08-15       Impact factor: 6.208

Review 7.  Disrupted Calcium Signaling in Animal Models of Human Spinocerebellar Ataxia (SCA).

Authors:  Francesca Prestori; Francesco Moccia; Egidio D'Angelo
Journal:  Int J Mol Sci       Date:  2019-12-27       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.